// App-Quantinova.ai

S205 : ZANUBRUTINIB + OBINUTUZUMAB (ZO) VS OBINUTUZUMAB (O) MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF THE PHASE 2 RANDOMIZED ROSEWOOD TRIAL

Researchers

Presenter

  • Pier Luigi Zinzani

Principal Investigators

  • Rebecca Auer

  • Fontanet Bijou

  • Christopher R. Flowers

  • Michele Merli

  • Krimo Bouabdallah

  • Peter S. Ganly

  • Yuqin Song

  • Huilai Zhang

  • Alejandro Martn Garca-Sancho

  • Mariano Provencio

  • Marek Trnen

  • Sam Yuen

  • Herve Tilly

  • Edwin Kingsley

  • Sarit E. Assouline

  • Elena Ivanova

  • Pil Kim

  • Jane Huang

  • Richard Delarue

  • Judith Trotman

Medical Centers

  • Hospital Universitario Puerta de Hierro — Majadahonda,Madrid,Spanien

  • Hospital Universitario de Salamanca,Salamanca,España

  • BeiGene Switzerland GmbH,Basel,Suiza

  • Vseobecna fakultní nemocnice v Praze,Prague,Tchèque, République

  • Hospital,Tianjin,Cina

  • Department of Internal Medicine-Hematology and Oncology,Masaryk University and University Hospital,Brno,Rep. Ceca

  • Comprehensive Cancer Centers of Nevada, Las Vegas, NV

  • BeiGene (Beijing) Co., L

  • Institut Bergonie, Bordeaux, France

  • Beijing Sanhuan Cancer Hospital, Beijing, China

  • Institut Bergonié,Bordeaux,Frankreich

  • University Hospital 'Ospedale di Circolo e Fondazione Macchi' - ASST Sette Laghi, University of Insubria,Varese,Italy

  • Vseobecna fakultni nemocnice v Praze,Prague,Rep. Ceca

  • BeiGene Switzerland GmbH,Basel,Suiza

  • Calvary Mater Newcastle,Waratah, New South Wales,Australien

  • Institut Bergonie, Bordeaux, France

  • Hospital Universitario De Salamanca-IBSAL, Salamanca, Spain

  • Comprehensive Cancer Centers of Nevada, Las Vegas, NV

  • Institut Bergonié,Bordeaux,Франция

  • Hôpital Haut-Lévêque, CHU Bordeaux,Pessac,France

  • University Hospital 'Ospedale di Circolo e Fondazione Macchi' - ASST Sette Laghi, University of Insubria,Varese,Italy

  • St. Bartholomew's Hospital, Barts Health NHS Trust,London,Vereinigtes Königreich

  • BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc.,San Mateo, CA,Vereinigte Staaten

  • CRLCC Henri Becquerel, Rouen, France

  • CRLCC Henri Becquerel, Rouen, France

  • BeiGene Switzerland GmbH,Basel,Suiza

  • Department of Haematology, Christchurch Hospital, Christchurch, New Zealand

  • St. Bartholomew's Hospital, Barts Health NHS Trust,London,Regno Unito

  • Vseobecna fakultní nemocnice v Praze,Prague,Tchèque, République

  • Tianjin Medical University Cancer Institute and...

  • Hospital Universitario De Salamanca-IBSAL, Salamanca, Spain

  • Department of Haematology, Christchurch Hospital, Christchurch, New Zealand

  • Centre Henri Becquerel,Rouen,Франция

  • Concord Repatriation General Hospital, Concord, NSW, Australia

  • Institut Bergonie, Bordeaux, France

  • Hematology

  • Jewish General Hospital, Montreal, QC, Canada

  • Comprehensive Cancer Centers of Nevada, Las Vegas, NV

  • Hospital,Tianjin,Cina

  • Hospital Universitario Puerta de Hierro — Majadahonda,Madrid,Spanien

  • BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc.,San Mateo, CA,Vereinigte Staaten

  • Hospital Universitario Puerta de Hierro, Madrid, Spain

  • CRLCC Henri Becquerel, Rouen, France

  • Institut Bergonié,Bordeaux,Frankreich

  • BeiGene Switzerland GmbH,Basel,Suiza

  • BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc.,San Mateo, CA,Vereinigte Staaten

  • Hospital Universitario De Salamanca-IBSAL, Salamanca, Spain

  • Vseobecna fakultni nemocnice v Praze,Prague,Rep. Ceca

  • Department of Internal Medicine-Hematology and Oncology,Masaryk University and University Hospital,Brno,Rep. Ceca

  • St. James's University Hospital, Leeds, United Kingdom

  • St. James University Hospital,Leeds,Vereinigtes Königreich

  • Concord Repatriation General Hospital, Concord, NSW, Australia

  • Hospital Universitario de Salamanca,Salamanca,España

  • Department of Chemotherapy of Hemoblastosis,Blokhin Russian Cancer Research Center,Moscow,Russ

  • Department of Haematology,Christchu

  • Department of Haematology, Christchurch Hospital, Christchurch, New Zealand

  • Hospital Universitario De Salamanca-IBSAL, Salamanca, Spain

  • Institut Catala d'Oncologia (ICO) Hospital Duran I Reynals, Hospital,Barcelona,Spanien

  • Department of Lymphoma and Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, TX

  • Institut Catala d'Oncologia (ICO) Hospital Duran I Reyn

  • Department of Lymphoma and Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, TX

  • BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc.,San Mateo, CA,Vereinigte Staaten

  • Jewish General Hospital, Montreal, QC, Canada

  • St Bartholomews Hospital, Barts Health NHS Trust, , United Kingdom

  • Vseobecna fakultní nemocnice v Praze,Prague,Tchèque, République

  • Všeobecná fakultní nemocnice v Praze

  • Department of Internal Medicine-Hematology and Oncology,Masaryk University and University Hospital,Brno,Rep. Ceca

  • St James's University Hospital,Leeds,Royaume-uni

  • Hospital,Tianjin,Cina

  • BeiGene Switzerland GmbH,Basel,Suiza

  • Beijing Cancer Hospital, Beijing/CN

  • Hôpital Haut-Leveque C.H.U. de Bordeaux, Pessac, France

  • BeiGene Switzerland GmbH,Basel,Швейцария

  • Department of Lymphoma and Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, TX

  • St. Bartholomew's Hospital, Barts Health NHS Trust,London,Regno Unito

  • Jewish General Hospital,Montreal,Канада

  • University Hospital 'Ospedale di Circolo e Fondazione Macchi' - ASST Sette Laghi, University of Insubria,Varese,Italy

  • Centre Henri-Becquerel,Rouen,Frankrijk

  • Concord Repatriation General Hospital,S

  • St. James's University Hospital,Leeds,Reino Unido

  • BeiGene Switzerland GmbH,Basel,Suiza

  • Department of internal medicine

  • Hôpital Haut-Lévêque, CHU Bordeaux,Pessac,Frankrijk

  • Calvary Mater Newcastle,Waratah, New South Wales,Australien

  • Institute of Hematology 'Seràgnoli'

  • Department of Chemotherapy of Hemoblastosis,Blokhin Russian Cancer Research Center,Moscow,Russ

  • Beijing Sanhuan Cancer Hospital, Beijing, China

  • Comprehensive Cancer Centers of Nevada,Las Vegas, NV,Verenigde Staten

  • Department of Haematology, Christchurch Hospital, Christchurch, New Zealand

  • Concord Repatriation General Hospital, Concord, NSW, Australia

  • St. Bartholomew's Hospital, Barts He

  • Calvary Mater Newcastle,Waratah, New South Wales,Australien

  • Institut Catala d'Oncologia (ICO) Hospital Duran I Reynals, Hospital,Barcelona,Spanien

  • Hôpital Haut-Lévêque, CHU Bordeaux,Pessac,France

  • Beijing Cancer Hospital, Beijing/CN

  • BeiGene Switzerland GmbH,Basel,Suiza

  • Hospital Universitario Puerta de Hierro — Majadahonda,Madrid,Spanien

  • Institut Catala d'Oncologia (ICO) Hospital Duran I Reynals, Hospital,Barcelona,Spanien

  • Institute of Hematology, University of Bologna, Bologna, Italy

  • Hospital Universitario de Salamanca,Salamanca,España

  • Hôpital Haut-Lévêque, CHU Bordeaux,Pessac,Франци

  • Institut Catala d'Oncologia (ICO) Hospital Duran I Reynals, Hospital,Barcelona,Spanien

  • Institute of Hematology, University of Bologna, Bologna, Italy

  • Institute of Hematology, University of Bologna, Bologna, Italy

  • CRLCC Henri Becquerel, Rouen, France

  • Department of Chemotherapy of Hemoblastosis,Blokhin Russian Cancer Research Center,Moscow,Russ

  • Institut Bergonie, Bordeaux, France

  • Hôpital Haut-Lévêque, CHU Bordeaux,Pessac,France

  • Calvary Mater Newcastle,Waratah, New South Wales,Australien

  • Tianjin Medical

  • Hospital Universitario Puerta de Hierro — Majadahonda,Madrid,Spanien

  • CRLCC Henri Becquerel, Rouen, France

  • Calvary Mater Newcastle, Waratah, NSW, Australia

  • St. James's University Hospital,Leeds,Reino Unido

  • Comprehensive Cancer Centers of Nevada, Las Vegas, NV

  • St. James's University Hospital Trust,Leed

  • Hospital Universitario de Burgos

  • Department of Lymphoma and Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, TX

  • Department of Haematology, Christchurch Hospital, Christchurch, New Zealand

  • St. Bartholomew's Hospital, Barts Health NHS Trust,London,Regno Unito

  • Jewish General Hospital, Montreal, QC, Canada

  • St. James University Hospital,Leeds,Vereinigtes Königreich

  • Vseobecna fakultni nemocnice v Praze,Prague,Rep. Ceca

  • Comprehensive Cancer Centers of Nevada, Las Vegas, NV

  • Institute of Hematology, University of Bologna, Bologna, Italy

Locations

  • Italy

  • Czech Republic

  • United Kingdom

  • France

  • Venezuela

  • Spain

  • United States

  • New Zealand

  • China

  • Mexico

  • South Africa

  • Australia

  • Russia

  • Canada

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Follicular lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Obinutuzumab

  • Obinutuzumab Intravenous

Outcome

  • N/A

Study Design

  • Randomized

  • Cross Over

Phase

  • II

Study Id's

  • NCT03332017

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved